BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $29

OrthoPediatrics Corp.

OrthoPediatrics Corp.

KIDS

0.00

BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ: KIDS) with a Buy and raises the price target from $24 to $29.